Early myoclonic encephalopathy (EME) is a rare neonatal-onset epilepsy developmental and epileptic encephalopathy (DEE) with an onset at neonatal period or during the first 3 months of life.[2] This syndrome is now included as part of the Early infantile developmental and epileptic encephalopathy (EIDEE) under the 2022 ILAE (International League Against Epilepsy) syndrome classification.[3][4]
Epidemiology
The prevalence estimates among EME are of <1 / 1 000 000.[5]
References
^Berg, AT; Berkovic, SF; Brodie, MJ; Buchhalter, J; Cross, JH; et al. (Apr 2010). "Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009". Epilepsia. 51 (4): 676–85. doi:10.1111/j.1528-1167.2010.02522.x. PMID20196795.
^Guerrini, R; Aicardi, J (November 2003). "Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy)". Journal of Clinical Neurophysiology. 20 (6): 449–61. doi:10.1097/00004691-200311000-00007. PMID14734934. S2CID20217683.